X
14Oct

Phoenix Laboratory Transition to the VISION Analyzer

0 Comments | | Return |

On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.

We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications

 

Related

CTS Implements HLA Class I and II Testing on the Gemini

CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...

Read More >

Reminder- Check flights and cargo hours for the New Year's Day Holiday

As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...

Read More >

Shipping conditions for Monolisa anti-HBs EIA

After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...

Read More >

Reminder- ZIKV Testing Strategy Webinar Wednesday 8/15/18

Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...

Read More >

Reminder-Revised Client Forms

 Just a reminder that the revised client forms implement today! Don't forget to toss your o...

Read More >

CTS Dallas Implements New Laboratory Information System

On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...

Read More >

Subscribe here to receive CTS updates!

Name